Уважаемые пользователи!
Мы рады представить вам новую версию сайта с улучшенным интерфейсом и новыми возможностями.
Приглашаем вас ознакомиться и поделиться обратной связью. Спасибо, что вы с нами!
Попробовать!
RUEN
Разместить новость

CVD risk higher for women aged at least 30 years with PCOS

06.04.20151518
Among women with polycystic ovary syndrome, those aged 30 years or older are potentially at higher risk for developing early atherosclerosis, based on elevated lipid levels, lipid ratios and hypertension rates, compared with younger women with or without polycystic ovary syndrome, according to research in the International Journal of Endocrinology.

New clinical trial will study smaller version of temporary total artificial heart

03.04.20151858
SynCardia Systems, Inc. announced FDA approval of a clinical trial to investigate a smaller version of its temporary artificial heart as a bridge to donor heart transplant in patients with HF, according to a press release.

The new update from AHA/ACC/ASH clarifies the treatment targets in those with CAD as well as CAD with other cardiovascular conditions

02.04.20152116
Physicians should aim to treat blood pressure to a target of less than 140/90 mm Hg for the majority of patients with coronary artery disease (CAD) and hypertension, according to a new update to the US guidelines for managing hypertension.

II Global Educational Forum "Russian Cardiovascular Days"

01.04.20152333
Meeting Reception of the Working Group of Young Cardiologists

Number of births may affect atherosclerosis risk in women

01.04.20151844
The number of live births is associated with subclinical coronary and aortic atherosclerosis in women, according to new data from the Dallas Heart Study.

Weight loss improves afib symptoms but fluctuation worsens them

31.03.20152071
Analyzing the link between obesity and arrhythmia, LEGACY confirmed that among obese patients, weight loss greatly influenced freedom from atrial fibrillation, particularly among those who lost weight and maintained it.

New administration option for ticagrelor now approved

30.03.20152055
For patients with ACS who are unable to swallow whole tablets, ticagrelor is now approved by the FDA to be crushed and administered in water by swallowing or via nasogastric tube, according to an announcement from AstraZeneca.
123...212213214215216...359360361
Enter the Society
Subscribe to Newsletter
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.